Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 15.21
(2.22%)
CNY 15.21
(2.22%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.86 Billion CNY | 2.79% |
| 2022 | 3.76 Billion CNY | 16.5% |
| 2021 | 3.22 Billion CNY | -21.45% |
| 2020 | 4.1 Billion CNY | -66.18% |
| 2019 | 12.15 Billion CNY | -12.99% |
| 2018 | 13.96 Billion CNY | 11.2% |
| 2017 | 12.55 Billion CNY | 40.78% |
| 2016 | 8.91 Billion CNY | 15.75% |
| 2015 | 7.7 Billion CNY | -1.87% |
| 2014 | 7.85 Billion CNY | 29.4% |
| 2013 | 6.06 Billion CNY | 85.06% |
| 2012 | 3.27 Billion CNY | 14.74% |
| 2011 | 2.85 Billion CNY | 40.95% |
| 2010 | 2.02 Billion CNY | 9.36% |
| 2009 | 1.85 Billion CNY | 36.82% |
| 2008 | 1.35 Billion CNY | 21.04% |
| 2007 | 1.11 Billion CNY | -27.29% |
| 2006 | 1.53 Billion CNY | 29.45% |
| 2005 | 1.18 Billion CNY | 43.94% |
| 2004 | 826.41 Million CNY | 43.54% |
| 2003 | 575.74 Million CNY | 126.94% |
| 2002 | 253.69 Million CNY | -27.14% |
| 2001 | 348.19 Million CNY | 31.82% |
| 2000 | 264.14 Million CNY | 22.69% |
| 1999 | 215.28 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.6 Billion CNY | 1.47% |
| 2024 Q3 | 3.81 Billion CNY | -17.13% |
| 2024 Q1 | 4.53 Billion CNY | 17.45% |
| 2023 Q2 | 4.66 Billion CNY | -5.61% |
| 2023 Q3 | 4.95 Billion CNY | 6.09% |
| 2023 Q4 | 3.86 Billion CNY | -21.98% |
| 2023 FY | 3.86 Billion CNY | 2.79% |
| 2023 Q1 | 4.94 Billion CNY | 31.56% |
| 2022 Q1 | 3.69 Billion CNY | 14.34% |
| 2022 FY | 3.76 Billion CNY | 16.5% |
| 2022 Q4 | 3.76 Billion CNY | -1.1% |
| 2022 Q3 | 3.8 Billion CNY | 13.98% |
| 2022 Q2 | 3.33 Billion CNY | -9.62% |
| 2021 Q3 | 2.8 Billion CNY | -5.95% |
| 2021 Q1 | 3.77 Billion CNY | -8.04% |
| 2021 FY | 3.22 Billion CNY | -21.45% |
| 2021 Q2 | 2.97 Billion CNY | -21.19% |
| 2021 Q4 | 3.22 Billion CNY | 15.23% |
| 2020 Q4 | 4.1 Billion CNY | -7.13% |
| 2020 FY | 4.1 Billion CNY | -66.18% |
| 2020 Q1 | 12.24 Billion CNY | 0.79% |
| 2020 Q2 | 11.07 Billion CNY | -9.56% |
| 2020 Q3 | 4.42 Billion CNY | -60.04% |
| 2019 Q2 | 13.24 Billion CNY | 2.68% |
| 2019 Q4 | 12.15 Billion CNY | -3.15% |
| 2019 Q3 | 12.54 Billion CNY | -5.26% |
| 2019 Q1 | 12.89 Billion CNY | -7.64% |
| 2019 FY | 12.15 Billion CNY | -12.99% |
| 2018 Q1 | 13.32 Billion CNY | 6.13% |
| 2018 FY | 13.96 Billion CNY | 11.2% |
| 2018 Q4 | 13.96 Billion CNY | 4.93% |
| 2018 Q3 | 13.3 Billion CNY | -2.43% |
| 2018 Q2 | 13.63 Billion CNY | 2.34% |
| 2017 Q3 | 11.78 Billion CNY | 10.74% |
| 2017 FY | 12.55 Billion CNY | 40.78% |
| 2017 Q1 | 9.43 Billion CNY | 5.81% |
| 2017 Q2 | 10.64 Billion CNY | 12.75% |
| 2017 Q4 | 12.55 Billion CNY | 6.56% |
| 2016 Q3 | 7.64 Billion CNY | -2.2% |
| 2016 Q2 | 7.82 Billion CNY | 6.02% |
| 2016 Q4 | 8.91 Billion CNY | 16.62% |
| 2016 Q1 | 7.37 Billion CNY | -4.27% |
| 2016 FY | 8.91 Billion CNY | 15.75% |
| 2015 FY | 7.7 Billion CNY | -1.87% |
| 2015 Q4 | 7.7 Billion CNY | 2.7% |
| 2015 Q3 | 7.5 Billion CNY | 1.8% |
| 2015 Q2 | 7.37 Billion CNY | 4.99% |
| 2015 Q1 | 7.02 Billion CNY | -10.61% |
| 2014 Q2 | 7.12 Billion CNY | 3.38% |
| 2014 FY | 7.85 Billion CNY | 29.4% |
| 2014 Q1 | 6.89 Billion CNY | 13.55% |
| 2014 Q4 | 7.85 Billion CNY | 9.13% |
| 2014 Q3 | 7.19 Billion CNY | 1.0% |
| 2013 Q3 | 6.15 Billion CNY | 13.92% |
| 2013 Q2 | 5.4 Billion CNY | 50.61% |
| 2013 FY | 6.06 Billion CNY | 85.06% |
| 2013 Q4 | 6.06 Billion CNY | -1.43% |
| 2013 Q1 | 3.58 Billion CNY | 9.42% |
| 2012 Q1 | 2.74 Billion CNY | -4.0% |
| 2012 Q2 | 2.79 Billion CNY | 1.8% |
| 2012 FY | 3.27 Billion CNY | 14.74% |
| 2012 Q3 | 3.04 Billion CNY | 9.04% |
| 2012 Q4 | 3.27 Billion CNY | 7.66% |
| 2011 FY | 2.85 Billion CNY | 40.95% |
| 2011 Q4 | 2.85 Billion CNY | 32.5% |
| 2011 Q3 | 2.15 Billion CNY | 4.12% |
| 2011 Q2 | 2.07 Billion CNY | 27.0% |
| 2011 Q1 | 1.63 Billion CNY | -19.55% |
| 2010 Q2 | 1.97 Billion CNY | 9.18% |
| 2010 Q3 | 1.93 Billion CNY | -2.29% |
| 2010 Q1 | 1.8 Billion CNY | -2.39% |
| 2010 Q4 | 2.02 Billion CNY | 5.03% |
| 2010 FY | 2.02 Billion CNY | 9.36% |
| 2009 Q2 | 1.56 Billion CNY | -0.09% |
| 2009 Q4 | 1.85 Billion CNY | -1.01% |
| 2009 Q1 | 1.56 Billion CNY | 15.74% |
| 2009 FY | 1.85 Billion CNY | 36.82% |
| 2009 Q3 | 1.87 Billion CNY | 19.53% |
| 2008 Q4 | 1.35 Billion CNY | -6.1% |
| 2008 FY | 1.35 Billion CNY | 21.04% |
| 2008 Q1 | 1.39 Billion CNY | 24.75% |
| 2008 Q2 | 1.49 Billion CNY | 7.17% |
| 2008 Q3 | 1.44 Billion CNY | -3.59% |
| 2007 FY | 1.11 Billion CNY | -27.29% |
| 2007 Q4 | 1.11 Billion CNY | 1.53% |
| 2007 Q3 | 1.1 Billion CNY | -13.53% |
| 2007 Q2 | 1.27 Billion CNY | -13.72% |
| 2007 Q1 | 1.47 Billion CNY | -4.0% |
| 2006 Q3 | 1.44 Billion CNY | 0.13% |
| 2006 Q4 | 1.53 Billion CNY | 6.24% |
| 2006 Q2 | 1.44 Billion CNY | -8.69% |
| 2006 FY | 1.53 Billion CNY | 29.45% |
| 2006 Q1 | 1.58 Billion CNY | 33.27% |
| 2005 Q4 | 1.18 Billion CNY | 32.25% |
| 2005 FY | 1.18 Billion CNY | 43.94% |
| 2005 Q1 | 926.85 Million CNY | 12.15% |
| 2005 Q2 | 990.76 Million CNY | 6.9% |
| 2005 Q3 | 899.44 Million CNY | -9.22% |
| 2004 Q1 | 568.6 Million CNY | -1.24% |
| 2004 Q4 | 826.41 Million CNY | 4.15% |
| 2004 Q3 | 793.5 Million CNY | 16.22% |
| 2004 Q2 | 682.76 Million CNY | 20.08% |
| 2004 FY | 826.41 Million CNY | 43.54% |
| 2003 Q1 | 311.25 Million CNY | 22.69% |
| 2003 Q2 | 451.44 Million CNY | 45.04% |
| 2003 FY | 575.74 Million CNY | 126.94% |
| 2003 Q3 | 534.09 Million CNY | 18.31% |
| 2003 Q4 | 575.74 Million CNY | 7.8% |
| 2002 FY | 253.69 Million CNY | -27.14% |
| 2002 Q2 | 381.03 Million CNY | 0.0% |
| 2002 Q4 | 253.69 Million CNY | -2.19% |
| 2002 Q3 | 259.38 Million CNY | -31.93% |
| 2001 FY | 348.19 Million CNY | 31.82% |
| 2000 FY | 264.14 Million CNY | 22.69% |
| 1999 FY | 215.28 Million CNY | 0.0% |